Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.03 AUD | -3.23% | -9.09% | -26.83% |
22/02 | PharmX Technologies Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Sales 2022 | 11.95M 7.81M 651M | Sales 2023 | 6.13M 4M 334M | Capitalization | 22.1M 14.44M 1.2B |
---|---|---|---|---|---|
Net income 2022 | - 0 0 | Net income 2023 | -1M -653K -54.46M | EV / Sales 2022 | 1.24 x |
Net cash position 2022 | 5.43M 3.55M 296M | Net cash position 2023 | 12.77M 8.34M 696M | EV / Sales 2023 | 1.52 x |
P/E ratio 2022 |
85.2
x | P/E ratio 2023 |
-20.8
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 40.97% |
1 week | -9.09% | ||
Current month | -3.23% | ||
3 months | -16.67% | ||
6 months | -30.23% | ||
Current year | -26.83% |
Date | Price | Change | Volume |
---|---|---|---|
22/24/22 | 0.03 | -3.23% | 286,950 |
17/24/17 | 0.031 | -3.13% | 190,759 |
Delayed Quote Australian S.E., April 22, 2024 at 05:45 am IST
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+18.66% | 414B | |
+15.27% | 242B | |
+12.15% | 144B | |
+20.63% | 104B | |
+17.19% | 83.87B | |
+54.11% | 57.64B | |
+33.59% | 53.37B | |
+6.02% | 37.83B | |
+15.88% | 32.51B |
- Stock Market
- Equities
- PHX Stock
- PHX Stock